Table 1 Demographics and clinical characteristics in the study population
| Â | Group 1 | Group 2 | Group 3 |
|---|---|---|---|
CAD | CVD | PAD | |
Number | 38 | 9 | 17 |
Male [%] | 31 (81.6) | 4 (44.4) | 13 (76.5) |
Age [years] | 66.0 ± 8 | 61.2 ± 8 | 68.7 ± 10 |
Weight [kg] | 87.2 ± 13 | 77.4 ± 12 | 89.7 ± 28 |
Height [m] | 1.69 ± 0.1 | 1.64 ± 0.1 | 1.7 ± 0.1 |
BMI [kg/m2] | 30.6 ± 4 | 28.7 ± 2 | 28.8 ± 4 |
Systolic BP [mmHg] | 135 ± 15 | 132 ± 12 | 137 ± 14 |
Diastolic BP [mmHg] | 76 ± 9 | 74 ± 8 | 78 ± 8 |
Hypertension | 32 (84.2) | 6 (66.7) | 13 (76.5) |
Antiplatelet | 34 (89) | 9 (100) | 15 (88) |
Antihypertensive | 37 (97) | 8 (89) | 14 (82) |
Statin prescription | 30 (79) | 8 (89) | 16 (94) |
Type 2 Diabetes | 19 (50) | 5 (55.6) | 6 (35.3) |
Non-Smokers | 16 (42) | 1 (11) | 1 (6) |
Former-Smokers | 20 (53) | 8 (89) | 11 (65) |
Smokers | 2 (5) | 0 (0) | 5 (29) |